Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma.
SAR442257(一种 CD38/CD3xCD28 三特异性 T 细胞衔接剂)在复发/难治性多发性骨髓瘤治疗中的临床前评估
期刊:Cells
影响因子:5.2
doi:10.3390/cells13100879
Grab Anna Luise, Kim Peter S, John Lukas, Bisht Kamlesh, Wang Hongfang, Baumann Anja, Van de Velde Helgi, Sarkar Irene, Shome Debarati, Reichert Philipp, Manta Calin, Gryzik Stefanie, Reijmers Rogier M, Weinhold Niels, Raab Marc S